Mast & CO SRL
Mast & CO reported total assets of €1.36m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
The score of Mast & CO shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +64 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mast & CO's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 12 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Mast & CO's financial analysis
- Solvency59.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mast & CO
Mast & CO's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0839.457.596
- VAT number
- BE0839457596
- Peppol
- Registered · 0208:0839457596 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Sep 2011
- Registered office
- 1785 Merchtem
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mast & CO (SRL) has been based in Merchtem since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 115,024 € and equity of 817,461 €; its revenue is not published. Its solvency stands at 59.9%, above the median of its sector (44.0%).
Companies similar to Mast & CO
Companies in the same business, of comparable size and area, outside its group.
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apogrez Retail sale of pharmaceutical products Grez-Doiceau · balance sheet €1.37m
- AD Pharma Retail sale of pharmaceutical products Châtelet · balance sheet €1.37m
- Geerts Farma Retail sale of pharmaceutical products Vilvoorde · balance sheet €1.38m
- Apotheek Zuiderkruis Retail sale of pharmaceutical products Antwerp · balance sheet €1.35m
- EVDW Retail sale of pharmaceutical products Ghent · balance sheet €1.38m
Frequently asked questions about Mast & CO
What is the revenue of Mast & CO?
Mast & CO files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mast & CO?
In Belgium, the VAT number is the company number prefixed with BE: BE0839457596 for Mast & CO, if the company is VAT-registered. Its company number (CBE) is 0839.457.596.
Where is the registered office of Mast & CO?
According to the CBE register, the registered office of Mast & CO is in 1785 Merchtem.
What is the equity of Mast & CO?
At the close of the 2025 financial year, the equity of Mast & CO amounts to 817,461 €, a solvency of 59.9% of total assets.
Who manages Mast & CO?
The register lists 1 active mandates at Mast & CO. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mast & CO
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →